 CDK inhibitors can be used in combination with endocrine or aromatase therapy.Chemotherapy is predominantly used for cases of breast cancer in stages 2–4, and is particularly beneficial in estrogen receptor-negative (ER-) disease.The chemotherapy medications are administered in combinations, usually for periods of 3–6 months.